JiMED designs and develops an AI-based brain-computer interface for implants in ALS patients to improve communication.
JiMED has raised $2.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2026.
JiMED's investors include Mizuho Capital, Keio Innovation Initiative, Kyoto University Innovation Capital, Osaka University Venture Capital, Senshu Ikeda Capital.
JiMED is headquartered in Suita, Japan.
JiMED designs and develops an AI-based brain-computer interface for implants in ALS patients to improve communication.
JiMED is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"JiMED — Funding & Investors." VCBacked, June 18, 2026, https://www.vcbacked.co/company/jimed. Accessed November 14, 2026.
VCBacked. (2026). JiMED — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/jimed
{{cite web |title=JiMED — Funding & Investors |url=https://www.vcbacked.co/company/jimed |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at JiMED? Request a listing update